AvenCell
Cell & Gene Therapy · Biotechnology

AvenCell news and milestones

AvenCell: 9 headlines on record, 4 headlines in the last 90 days. Its story counts 2 milestones.

Data updated Nov 20, 2026 · Back to the company report
9Headlines
4In 90 days
2Milestones

Headlines

Sep 292026
News · YahooFinance
Ligand Pharmaceuticals recently entered a US$47 million financing agreement with AvenCell Therapeutics, including up to US$6 million in Series C funding and as much as US$41 mill…
Sep 272026
News · YahooFinance
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) is building a business model that differs from that of many drug developers. Rather than relying on internally operated drug dev…
Sep 242026
News · baystreet.ca
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that it has entered into a financing agreement with AvenCell Therapeutics, Inc., a clinical-stage cell therapy…
Sep 242026
News · RTTNews
Thursday, Ligand Pharmaceuticals Inc. (LGND) announced a financing agreement with AvenCell Therapeutics, Inc., a clinical-stage cell therapy company, for upto $47 million, helpin…
Sources: the outlets named on each headline, each story once

Milestones

Each milestone is dated by its source: registers, filings, the press

How to cite

AvenCell, News. Alion, Nov 20, 2026. https://alion.io/company/avencell/news

.json · .md · CC BY-SA 4.0